Market Overview:
The global 6-Azauracil (CAS 461-89-2) market is expected to register a CAGR of 5.5% during the forecast period, 2018–2030. The market growth can be attributed to the increasing demand for RNA synthesis inhibitors and antitumor drugs. In addition, the growing awareness about the benefits of 6-Azauracil (CAS 461-89-2) is also contributing to the market growth. However, stringent regulatory norms are restraining the growth of this market. On the basis of type, Purity ≥98% segment is expected to account for a major share in terms of revenue in 2018 and is projected to register a CAGR of 5.8% during 2018–2030 owing to its high purity levels and better therapeutic outcomes as compared with other types segments Purity ≥99%. On account on application, RNA synthesis inhibitors segment accounted for majority share in 2017 and it will continue its dominance over other applications segments throughout 2030 due rising incidences cancer across globe .
 Industry Outlook.svg)
Product Definition:
6-Azauracil is a nucleoside analogue, specifically a pyrimidine analogue. It inhibits DNA polymerase and is used as an antineoplastic agent.
Purity ≥98%:
Purity ≥98% is a special type of acylphosphine oxide. It has the highest purity level among all phosphine oxides. Purity levels of other products such as tri-azauracil and tetra-azauracil are not as high as that of purity ≥98%.
Purity ≥99%:
Purity 99% is a special grade of 6-azauracil used as an antiseptic and disinfectant. It has the highest concentration of 6-azauracil that can be obtained in any commercial source. Purity 99% is manufactured by two different processes, one involves crystallization from hot water and other from sodium carbonate solution which contains limestone (calcium carbonate).
Application Insights:
RNA synthesis inhibitors accounted for the largest revenue share of over 40.0% in 2017. The product is used as a nucleotide triphosphate (NTP) substrate during DNA and RNA synthesis, which provides protection against exogenous nucleotides and prevents degradation of cDNA products by ribonucleases present in the cell. Thus, it is widely used in various applications such as gene amplification, Northern Blotting and sequencing etc., across research studies.
The antitumor application segment is expected to witness the fastest growth rate over the forecast period owing to increasing awareness about cancer-related issues coupled with rising government funding for cancer research & development activities globally. 6-Azaauracil has been observed to be effective against various types of cancers such as skin melanoma, breast carcinoma & osteosarcoma etc.
Regional Analysis:
North America was the largest regional market for 6-Azaouracil with a share of over 40.0% in 2017 owing to the presence of major manufacturers coupled with high healthcare expenditure and research & development (R&D) activities. The region is expected to maintain its dominance during the forecast period due to factors such as favorable reimbursement policies, increasing prevalence of cancer, and rising awareness about available treatment options among patients.
Asia Pacific is anticipated to be one of the fastest growing regions during the forecast period owing to rapid economic growth in emerging countries such as China and India along with other Southeast Asian nations that have led them into being a global hub for manufacturing various pharmaceutical products at an affordable cost. This has resulted in increased demand for 6-azaouracil from these regions which will further boost market growth over the coming years.
Growth Factors:
- Increasing demand from pharmaceutical and biotechnology industries for 6-Azauracil as a research tool for drug discovery and development.
- Growing popularity of 6-Azauracil as an anticancer agent due to its ability to inhibit tumor growth and proliferation.
- Rising demand for 6-Azauracil in the field of agrochemicals owing to its use as a herbicide and fungicide.
- Increasing application of 6-Azauracil in dye production industry due to its excellent colorfastness properties.
Scope Of The Report
Report Attributes
Report Details
Report Title
6-Azauracil (CAS 461-89-2) Market Research Report
By Type
Purity ≥98%, Purity ≥99%
By Application
RNA Synthesis Inhibitors, Antitumor
By Companies
Merck KGaA, Hunan Huateng Pharmaceutical, Hangzhou Hairui Chemical, Sichuan Hainuowei, Liaoyang Jiulong Pharmaceutical Chemical, Shijiazhuang Jing Kang Technology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global 6-Azauracil (CAS 461-89-2) Market Report Segments:
The global 6-Azauracil (CAS 461-89-2) market is segmented on the basis of:
Types
Purity ≥98%, Purity ≥99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
RNA Synthesis Inhibitors, Antitumor
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KGaA
- Hunan Huateng Pharmaceutical
- Hangzhou Hairui Chemical
- Sichuan Hainuowei
- Liaoyang Jiulong Pharmaceutical Chemical
- Shijiazhuang Jing Kang Technology
 Market Overview.svg)
Highlights of The 6-Azauracil (CAS 461-89-2) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥98%
- Purity ≥99%
- By Application:
- RNA Synthesis Inhibitors
- Antitumor
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the 6-Azauracil (CAS 461-89-2) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
6-Azauracil is a white to off-white crystalline solid with a sweet odor. It is used as an intermediate in the production of other chemicals.
Some of the major companies in the 6-azauracil (cas 461-89-2) market are Merck KGaA, Hunan Huateng Pharmaceutical, Hangzhou Hairui Chemical, Sichuan Hainuowei, Liaoyang Jiulong Pharmaceutical Chemical, Shijiazhuang Jing Kang Technology.
The 6-azauracil (cas 461-89-2) market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 6-Azauracil (CAS 461-89-2) Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 6-Azauracil (CAS 461-89-2) Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 6-Azauracil (CAS 461-89-2) Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the 6-Azauracil (CAS 461-89-2) Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global 6-Azauracil (CAS 461-89-2) Market Size & Forecast, 2018-2028
4.5.1 6-Azauracil (CAS 461-89-2) Market Size and Y-o-Y Growth
4.5.2 6-Azauracil (CAS 461-89-2) Market Absolute $ Opportunity
Chapter 5 Global 6-Azauracil (CAS 461-89-2) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
5.2.1 Purity ≥98%
5.2.2 Purity ≥99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global 6-Azauracil (CAS 461-89-2) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
6.2.1 RNA Synthesis Inhibitors
6.2.2 Antitumor
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global 6-Azauracil (CAS 461-89-2) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 6-Azauracil (CAS 461-89-2) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America 6-Azauracil (CAS 461-89-2) Analysis and Forecast
9.1 Introduction
9.2 North America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
9.6.1 Purity ≥98%
9.6.2 Purity ≥99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
9.10.1 RNA Synthesis Inhibitors
9.10.2 Antitumor
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe 6-Azauracil (CAS 461-89-2) Analysis and Forecast
10.1 Introduction
10.2 Europe 6-Azauracil (CAS 461-89-2) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
10.6.1 Purity ≥98%
10.6.2 Purity ≥99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
10.10.1 RNA Synthesis Inhibitors
10.10.2 Antitumor
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific 6-Azauracil (CAS 461-89-2) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific 6-Azauracil (CAS 461-89-2) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
11.6.1 Purity ≥98%
11.6.2 Purity ≥99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
11.10.1 RNA Synthesis Inhibitors
11.10.2 Antitumor
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America 6-Azauracil (CAS 461-89-2) Analysis and Forecast
12.1 Introduction
12.2 Latin America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
12.6.1 Purity ≥98%
12.6.2 Purity ≥99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
12.10.1 RNA Synthesis Inhibitors
12.10.2 Antitumor
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) 6-Azauracil (CAS 461-89-2) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) 6-Azauracil (CAS 461-89-2) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) 6-Azauracil (CAS 461-89-2) Market Size Forecast by Type
13.6.1 Purity ≥98%
13.6.2 Purity ≥99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) 6-Azauracil (CAS 461-89-2) Market Size Forecast by Applications
13.10.1 RNA Synthesis Inhibitors
13.10.2 Antitumor
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 6-Azauracil (CAS 461-89-2) Market: Competitive Dashboard
14.2 Global 6-Azauracil (CAS 461-89-2) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck KGaA
14.3.2 Hunan Huateng Pharmaceutical
14.3.3 Hangzhou Hairui Chemical
14.3.4 Sichuan Hainuowei
14.3.5 Liaoyang Jiulong Pharmaceutical Chemical
14.3.6 Shijiazhuang Jing Kang Technology
